CARDIOMYOCYTE AS
1344 HASLUM
Return on Equity
1Â 587,39Â %
Current Ratio
1,03
Debt-to-Equity Ratio
0
| Key figures (NOK) | 2022 | |
|---|---|---|
| Revenue | 8Â 728Â 000 | |
| Net Income | 1Â 889Â 000 | |
| Total Assets | 3Â 005Â 000 | |
| Total Equity | 119Â 000 |
| Income (NOK) | 2022 | |
|---|---|---|
| Revenue | 8Â 728Â 000 | |
| Expenditure | 6Â 399Â 000 | |
| Operating Profit | 2Â 329Â 000 | |
| Financial Income | 140Â 000 | |
| Financial Costs | 66Â 000 | |
| Financial Balance | 74Â 000 | |
| Earnings Before Tax | 2Â 403Â 000 | |
| Tax | 514Â 000 | |
| Net Income | 1Â 889Â 000 |
| Balance (NOK) | 2022 | |
|---|---|---|
| Total Fixed Assets | 19Â 000 | |
| Total Current Assets | 2Â 986Â 000 | |
| Total Assets | 3Â 005Â 000 | |
| Total Retained Equity | 89Â 000 | |
| Total Equity | 119Â 000 | |
| Total Long-Term Debt | 0 | |
| Total Current Debt | 2Â 886Â 000 | |
| Total Equity and Debt | 3Â 005Â 000 |
| Cash flow (NOK) | 2022 | |
|---|---|---|
| Sales Income | 8Â 728Â 000 | |
| Other Income | 0 | |
| Revenue | 8Â 728Â 000 | |
| Cost of Goods Sold | 0 | |
| Salary Costs | 2Â 000Â 000 | |
| Depreciation | 22Â 000 | |
| Impairment | 0 | |
| Expenditure | 6Â 399Â 000 | |
| Operating Profit | 2Â 329Â 000 | |
| Financial Income | 140Â 000 | |
| Financial Costs | 66Â 000 | |
| Financial Balance | 74Â 000 | |
| Dividends | 1Â 800Â 000 | |
| Net Income | 1Â 889Â 000 |
| Balance details (NOK) | 2022 | |
|---|---|---|
| Goodwill | 0 | |
| Total Intangible Assets | 19Â 000 | |
| Real Eastate | 0 | |
| Machinery and Plant Facilities | 0 | |
| Fixtures | 0 | |
| Total Tangible Assets | 0 | |
| Total Fiancial Fixed Assets | 0 | |
| Total Fixed Assets | 19Â 000 | |
| Stock | 0 | |
| Total Investments | 0 | |
| Cash, Bank | 1Â 119Â 000 | |
| Total Current Assets | 2Â 986Â 000 | |
| Total Assets | 3Â 005Â 000 | |
| Total Equity | 119Â 000 | |
| Short-Term Group Debt | 0 | |
| Total Long-Term Debt | 0 | |
| Creditors | 206Â 000 | |
| Unpaid Taxes | 163Â 000 | |
| Dividends | 1Â 800Â 000 | |
| Other Current Debt | 207Â 000 | |
| Total Current Debt | 2Â 886Â 000 | |
| Total Equity and Debt | 3Â 005Â 000 |
| Financial indicators | 2022 | |
|---|---|---|
| Return on Equity | 1Â 587,39Â % | |
| Debt-to-Equity Ratio | 0 | |
| Operating Profit Margin | 26,68Â % | |
| Current Ratio | 1,03 | |
| Quick Ratio | 1,03 | |
| Equity Ratio | 0,04 | |
| Gross Profit Margin | 100Â % |
Rotate your device to see the full table